Cargando…
Pirfenidone Alleviates Choroidal Neovascular Fibrosis through TGF-β/Smad Signaling Pathway
Background. Transforming growth factor-β (TGF-β) plays a major role in CNV. However, the mechanism is unclear. This study investigates the effect of Pirfenidone (PFD) on TGF-β/Smad signaling pathway on the development of choroidal neovascular fibrosis in choroidal neovascularization (CNV) mouse mode...
Autores principales: | Gao, Chuang, Cao, Xin, Huang, Lili, Bao, Yueqi, Li, Tao, Di, Yue, Wu, Liucheng, Song, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889376/ https://www.ncbi.nlm.nih.gov/pubmed/33628482 http://dx.doi.org/10.1155/2021/8846708 |
Ejemplares similares
-
Pirfenidone ameliorates the formation of choroidal neovascularization in mice
por: Bao, Yueqi, et al.
Publicado: (2020) -
Pirfenidone alleviates cardiac fibrosis induced by pressure overload via inhibiting TGF‐β1/Smad3 signalling pathway
por: Li, Na, et al.
Publicado: (2022) -
Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways
por: Lv, Qun, et al.
Publicado: (2020) -
Pirfenidone modulates macrophage polarization and ameliorates radiation‐induced lung fibrosis by inhibiting the TGF‐β1/Smad3 pathway
por: Ying, Hangjie, et al.
Publicado: (2021) -
Inhibition of TGF-β2–Induced Trabecular Meshwork Fibrosis by Pirfenidone
por: Zhu, Xiaofeng, et al.
Publicado: (2023)